Previous 10 | Next 10 |
2023-09-08 00:03:09 ET Summary The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. ...
2023-09-07 08:31:06 ET Summary IQVIA's stock is expected to remain rangebound in the near term due to macroeconomic-driven weaknesses in TAS and CMS segments, causing caution in client spending decisions. The RDS segment remains competitive, but its long-term bookings may not sign...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023 at 10:50 a.m. ET. A live audio webcast ...
2023-09-01 13:30:55 ET Summary Veeva Systems focuses on optimizing operations and enhancing compliance for life sciences organizations. Veeva's Q2 2024 results align with expectations, showing no major surprises. Despite a not-so-cheap valuation, Veeva's steady growth makes it...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 12, 2023 at 11:30 a.m. ET. A live audio webcast of the pr...
2023-08-30 08:54:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips This year has not been kind to biotech stocks , as the sector’s most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so far in 2023. In...
2023-08-28 06:48:26 ET More on Elite Elite Pharmaceuticals, Inc. ( OTCQB:ELTP ) Q1 2024 Earnings Call Transcript Elite Pharmaceuticals, Inc. ( OTCQB:ELTP ) Q4 2023 Earnings Call Transcript Elite Pharmaceuticals enters exclusive distribution agreement with Pra...
2023-08-17 03:12:23 ET Summary William von Mueffling's 13F portfolio value increased by 17% to $14.31B in Q2 2023. The top five positions in the portfolio are Broadcom, S&P Global, Analog Devices, Visa, and Alphabet. New stakes include Live Nation Entertainment and Tradewe...
2023-08-03 05:15:44 ET Summary IQVIA Holdings Inc. has demonstrated impressive growth in Q2, beating earnings and revenue expectations. The company operates in multiple segments, including Technology & Analytics Solutions and Research & Development Solutions. IQVIA has...
2023-08-01 17:34:03 ET IQVIA Holdings Inc. (IQV) Q2 2023 Earnings Conference Call August 01, 2023 09:00 AM ET Company Participants Nick Childs - SVP, IR and Treasurer Ari Bousbib - Chairman and CEO Ron Bruehlman - EVP and CFO Conference Call Participants ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...